KNBWF
Kirin Holdings Company, Limited is a diversified enterprise with a significant presence in both Japan and global markets, focusing on alcoholic beverages, non-alcoholic drinks, pharmaceuticals, and various related ventures. Its operations are strategically organized into four key segments: the Japan Beer and Spirits Businesses, the Japan Non-Alcoholic Beverages Business, the Oceania Integrated Beverages Business, and the Pharmaceuticals Business. The company's extensive product portfolio encompasses a wide array of alcoholic offerings, including beer, happo-shu, wine, whiskey, and spirits. Its non-alcoholic selection features soft drinks, dairy items, and fruit juices. Beyond beverages, Kirin also develops and markets pharmaceutical and biochemical products. Its diverse activities extend to managing factories, operating a theme park, and running the Kirin City chain of beer pubs. Furthermore, it manufactures and sells specialized ingredients like amino acids and nucleic acids for pharmaceutical and industrial applications, along with bulk pharmaceuticals. The company also produces a variety of food items such as margarine, jams, honey, sake, and other food products, in addition to being involved in the production and sale of Coca-Cola products and other soft drinks. Kirin also oversees the manufacturing and supply of Four Roses bourbon and provides insurance agent services. Founded in 1885 and headquartered in Tokyo, Japan, the company was initially known as Kirin Brewery Company, Limited before rebranding to Kirin Holdings Company, Limited in July 2007.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 33.55 | $576.6B | $43.6B |
| 2025 Q4 | 54.90 | $677.8B | $53.8B |
| 2025 Q3 | 63.00 | $628.7B | $72.1B |
| 2025 Q2 | 35.18 | $590.5B | $21.7B |
| 2025 Q1 | 30.05 | $545.9B | -$26.7B |
| 2024 Q4 | -25.99 | $638.7B | -$19.2B |
| 2024 Q3 | 27.22 | $603.9B | $41.2B |
| 2024 Q2 | 38.67 | $594.1B |
| $22.4B |